Santa Cruz, CA, United States of America

Nicholas Lorig-Roach

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Henry Ford Health System, University of California. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas Lorig-Roach. Retrieved from https://idiyas.com/inventor/nicholas-lorig-roach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Nicholas Lorig-Roach

Introduction

Nicholas Lorig-Roach is an accomplished inventor based in Santa Cruz, California. He has made significant contributions to the field of therapeutic compounds, particularly through his innovative work on pyrroloquinolin compounds.

Latest Patents

Nicholas holds a patent for "Pyrroloquinolin compounds and methods of using same." This patent includes pyrroloquinolin compounds that are therapeutic in nature, specifically for treating cell proliferative disorders. The patent also covers conjugates that incorporate these compounds, as well as pharmaceutical compositions that utilize them. Additionally, it outlines therapeutic methods for administering these compounds and includes kits that feature the pyrroloquinolin compounds and their conjugates.

Career Highlights

Throughout his career, Nicholas has worked with notable institutions such as the University of California and Henry Ford Health System. His work has focused on developing innovative solutions in the medical field, particularly in the area of therapeutic compounds.

Collaborations

Nicholas has collaborated with esteemed colleagues, including Phillip Crews and Frederick A. Valeriote, contributing to the advancement of research in his field.

Conclusion

Nicholas Lorig-Roach's innovative work in developing pyrroloquinolin compounds showcases his dedication to advancing therapeutic methods. His contributions have the potential to significantly impact the treatment of cell proliferative disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…